Temporal trends in latecomer STEMI patients: insights from the AMIS Plus registry 1997-2017.
暂无分享,去创建一个
P. Erne | H. Rickli | G. Pedrazzini | L. Biasco | M. Moccetti | E. de Benedetti | D. Radovanovic | G. Halasz | M. Roberto | A. Quagliana | D. Radovanović
[1] Xiang Ma,et al. Invasive reperfusion after 12 hours of the symptom onset remains beneficial in patients with ST-segment elevation myocardial infarction: Evidence from a meta-analysis of published data , 2019, Cardiology journal.
[2] F. Eberli,et al. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry , 2019, Circulation. Cardiovascular interventions.
[3] E. Keeley,et al. Very late presentation in ST elevation myocardial infarction: Predictors and long-term mortality , 2019, International journal of cardiology. Heart & vasculature.
[4] G. Hindricks,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.
[5] B. Seifert,et al. Gender differences in the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20 years in Switzerland , 2017, Open Heart.
[6] E. Cerrato,et al. Characteristics, in-hospital management and outcome of late acute ST-elevation myocardial infarction presenters , 2017, Journal of cardiovascular medicine.
[7] R. Swaminathan,et al. Analysis of reperfusion time trends in patients with ST-elevation myocardial infarction across New York State from 2004 to 2012. , 2017, International journal of cardiology.
[8] T. Lüscher,et al. Inpatient versus outpatient onsets of acute myocardial infarction. , 2015, European journal of internal medicine.
[9] F. Eberli,et al. Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012 , 2013, Heart.
[10] Emily C. O'Brien,et al. Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study). , 2013, The American journal of cardiology.
[11] Á. Cequier,et al. Impact on delay times and characteristics of patients undergoing primary percutaneous coronary intervention in the southern metropolitan area of Barcelona after implementation of the infarction code program. , 2012, Revista espanola de cardiologia.
[12] Á. Cequier,et al. Impact on Delay Times and Characteristics of Patients Undergoing Primary Percutaneous Coronary Intervention in the Southern Metropolitan Area of Barcelona After Implementation of the Infarction Code Program , 2012 .
[13] B. Seifert,et al. Impact of a nationwide public campaign on delays and outcome in Swiss patients with acute coronary syndrome , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[14] P. Erne,et al. AMIS Plus: Swiss registry of acute coronary syndrome , 2010, Heart.
[15] A. Kastrati,et al. Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms. , 2009, JAMA.
[16] G. Lamas,et al. Coronary intervention for persistent occlusion after myocardial infarction. , 2006, The New England journal of medicine.
[17] A. Kastrati,et al. Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction. , 2006, European heart journal.
[18] G. Stone,et al. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. , 2006, American heart journal.
[19] S. Nekolla,et al. Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial , 2005 .
[20] K. Huber,et al. The Role of Gender and Other Factors as Predictors of Not Receiving Reperfusion Therapy and of Outcome in ST-Segment Elevation Myocardial Infarction , 2005, Journal of Thrombosis and Thrombolysis.
[21] Elliott M. Antman,et al. Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts , 2004, Circulation.
[22] F Van de Werf,et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. , 1996, Journal of the American College of Cardiology.